Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national blog main
4
×
new york blog main
san francisco blog main
boston blog main
boston top stories
national top stories
new york top stories
san francisco top stories
boston
fda
multiple myeloma
national
new york
raleigh-durham blog main
raleigh-durham top stories
rare disease drugs
san diego blog main
acute migrane
acute myeloid leukemia
alx oncology
antibiotics
arvinas
astellas pharma
astrazeneca
atlas venture
audentes therapeutics
autoimmune diseases
avidity biosciences
bain capital
bausch health
berkeley lights
biotech ipos
bluebird bio
boulder/denver
boulder/denver blog main
boulder/denver top stories
breast cancer
What
ipo
4
×
ipos
4
×
biotech
biotechs
companies
days
drug
hasn’t
life
science
slowed
week
activity
ago
arrival
chose
close
company
considering
data
device
diseases
dog
dyne
early
expected
experimental
eyes
firm
firms
genetic
having
humans
industry
leading
line
long
make
market
medical
Language
unset
Current search:
" national blog main "
×
ipo
×
ipos
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way